Clinical Trials
23 trialsNCT05051722 2026-04-17
ECHO
Mayo Clinic
Recruiting
NCT07276360 2026-03-27
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Recruiting
NCT03987555 2026-03-18
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
Suspended
NCT06349642 2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
NCT01181375 2026-03-05
Predictive Assays In Cervix Cancer
University Health Network, Toronto
Phase NA Active not recruiting
NCT05975593 2025-11-12
METEOR-CRATR
Washington University School of Medicine
Phase NA Recruiting
NCT05247853 2025-10-16
HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV
Montefiore Medical Center
Completed
NCT03958240 2025-09-15
DECIDE
Institut Claudius Regaud
Phase NA Recruiting
NCT02554565 2025-09-08
PAIR HPV
Institut Curie
Phase NA Terminated
NCT06263582 2025-08-19
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT07093593 2025-07-30
RAMA
Centre Georges Francois Leclerc
Phase NA Not yet recruiting
NCT06129253 2025-07-16
HPV
International Vaccine Institute
Recruiting
NCT04770090 2025-07-10
CTC-COL
University Hospital, Montpellier
Phase NA Completed
NCT05062707 2025-05-13
Early Ageing During Therapy in AYA Cancer Patients
University Medical Center Groningen
Recruiting
NCT03749720 2025-04-01
HPV in Blood Samples From Cervical Cancer Patients.
University of Aarhus
Phase NA Completed
NCT06016868 2023-08-30
MOLLY
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unknown
NCT02428842 2023-01-20
BIO-RAIDs
Institut Curie
Phase NA Completed
NCT04905576 2021-05-27
Quality of Life Interventions During Cervical Cancer Treatment
University of Iowa
Phase NA Completed
NCT00947115 2020-10-30
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
GlaxoSmithKline
Phase 3 Completed
NCT01546363 2020-10-05
Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer
Stanford University
Completed
NCT00877877 2020-01-18
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
GlaxoSmithKline
Phase 3 Completed
NCT02875990 2016-08-23
Xac03
Assistance Publique Hopitaux De Marseille
Phase NA Unknown
NCT02016833 2015-04-30
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
Completed